– because cancer patients are individuals

News and Press Releases

2019-12-10

News

2cureX launches IndiTreat.com as an important component of 2cureX’s preparation for the product launch of IndiTreat® in 2020

2cureX AB (“2cureX”, NASDAQ: 2CUREX) today announces that the company has launched www.IndiTreat.com. This website provides detailed information to colorectal...

2019-11-22

Press releases regulatory

2cureX publishes interim report for the third quarter of 2019

2cureX AB (“2cureX”) hereby publishes interim report for the third quarter of 2019. The interim report is available as an...

2019-11-06

News

2cureX continues its efforts to ensure a strong IP protection for its IndiTreat test in the United States

2cureX AB (“2cureX”, NASDAQ: 2CUREX) is pleased to announce that a patent on the IndiTreat® test has been granted in...

To the news archive

Meet 2cureX

March 17, 2020

Oncology Convention 2020, Birmingham, UK

Click here for more information

February 19-22, 2020

German Cancer Congress, 34 Deutscher Krebs Kongress 2020, Berlin, Germany

Click here for more information

December 11-14, 2019

ESMO Immuno-Oncology Congress 2019

Click here for more information

Contact information

2cureX, Fruebjergvej 3, 2100 Copenhagen Ø, Denmark| Phone: +45 2211 5399| E-mail: info@2curex.com

Privacy Policy | Imprint